autonomic and peripheral nerve functions as well as the possible short-term effect of a novel aldose reductase inhibitor ( ari ) on neuropathy were evaluated in 30 male type i diabetics ( age 25-44 years , mean 34 ; duration of diabetes 10-20 years , mean 34 ) with neurographic signs of peripheral neuropathy ( pn ) .
C0442874
neuropathy
C0031117
peripheral neuropathy